Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ERYTHROMYCIN ETHYLSUCCINATE

ERYTHROMYCIN ETHYLSUCCINATE

Standard Dose
EQ 400MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ERYTHROMYCIN ETHYLSUCCINATE is listed in Drugs@FDA under application 062847 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength TABLET;ORAL - EQ 400MG BASE Sponsor AUROBINDO PHARMA USA Submission history Latest submission status date: 2001-12-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN ETHYLSUCCINATE is listed in Drugs@FDA under application 062847 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength TABLET;ORAL - EQ 400MG BASE Sponsor AUROBINDO PHARMA USA Submission history Latest submission status date: 2001-12-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.